Traduction de «edss » (Anglais → Français) :

expanded disability status scale [ EDSS | Kurtzke's expanded disability status scale | extended disability status scale | Kurtzke extended disability status scale ]

Environmental Emergency Decision Support System | EDSS [Abbr.]

Economic Data Sharing System | EDSS

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) ho ...[+++]w is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...

EDSs are found in pharmaceuticals such as birth control pills, industrial chemicals such as PCBs, metals and plasticizers, fragrances and preservatives in cleaning and personal care products, contaminants such as dioxins, and pesticides such as the insect repellant DEET.

Endocrine-disrupting substances, or EDSs, may increase or decrease hormonal activity that controls many of the body's functions, including growth, development, and reproduction.

Many more animal studies, along with clinical research and statistical trends and patterns, are needed to establish consensus about the human health impacts of EDSs.